Other Income & Expense

Finance Lease Interest Payment

Vertex Pharmaceuticals Finance Lease Interest Payment remained flat by 0.0% to $1.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 78.2%, from $6.43M to $1.40M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest Payment shows a downward trend with a -61.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher interest payments relative to total lease payments suggest a higher cost of capital or more expensive lease terms.

Detailed definition

The portion of finance lease payments that is classified as interest expense rather than principal reduction. This metri...

Peer comparison

Standard for companies with significant capital lease obligations.

Metric ID: glw_finance_lease_interest_payment

Historical Data

3 years
 FY'23FY'24FY'25
Value$38.40M$25.70M$5.60M
YoY Change-33.1%-78.2%
Range$5.60M$38.40M
CAGR-61.8%
Avg YoY Growth-55.6%
Median YoY Growth-55.6%
Current Streak2+ years decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's finance lease interest payment?
Vertex Pharmaceuticals (VRTX) reported finance lease interest payment of $1.40M in Q4 2025.
How has Vertex Pharmaceuticals's finance lease interest payment changed year-over-year?
Vertex Pharmaceuticals's finance lease interest payment decreased by 78.2% year-over-year, from $6.43M to $1.40M.
What is the long-term trend for Vertex Pharmaceuticals's finance lease interest payment?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's finance lease interest payment has grown at a -61.8% compound annual growth rate (CAGR), from $38.40M to $5.60M.
What does finance lease interest payment mean?
The interest cost paid as part of the company's finance lease agreements.